It is often detected too late, as diagnostic methods that allow ... unnecessary biopsies performed. The iToBoS scanner ...
Hosted on MSN11mon
Bosch and Randox to expand molecular diagnostics in $159m partnershipBosch Healthcare and diagnostic company Randox will invest $159m (€150m) to expand the former company’s Vivalytic analysis platform. The funds from the strategic partnership will see the two ...
A project consortium funded by the EU and including the Fraunhofer Heinrich Hertz Institute (Fraunhofer HHI) has developed a novel platform for early detection of skin cancer. The iToBoS (Intelligent ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results